FTC sues Enforma
This article was originally published in The Tan Sheet
Executive Summary
Civil contempt charges filed by FTC Jan. 3 against Enforma Natural Products; hearing is scheduled for Feb. 4 in Los Angeles federal court. Commission alleges Enforma "blatantly disregarded" a May 2000 order by continuing to make unsubstantiated claims about its Fat Trapper Plus and Exercise In A Bottle weight-loss products (1"The Tan Sheet" May 1, 2000, p. 17). FTC requests order requiring defendants cease use of trade names Fat Trapper, Fat Trapper Plus and Exercise in a Bottle, and turn over all gross revenues from sale of products at issue since May 2000...
You may also be interested in...
Enforma To Cease Deceptive Weight Loss Claims, Pay $10 Mil. -FTC
Enforma Natural Products settles Federal Trade Commission charges that it made false and unsubstantiated weight loss claims in an infomercial and on the Internet, without admitting a violation of law, the agency announces April 26.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.